Sharing Risk between Payer and Provider by Leasing Health Technologies: An Affordable and Effective Reimbursement Strategy for Innovative Technologies?

Overview of attention for article published in Value in Health (Elsevier Science), April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy: 1 policy source
twitter: 9 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 126 Mendeley

Summary Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Gene Therapy: International Regulatory and Health Technology Assessment (HTA) Activities and Reimbursement Status

Cited by Canadian Agency for Drugs and Technologies in Health on 23 Feb 2017

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.